Impact of tocilizumab administration on mortality in severe COVID-19
Crossref DOI link: https://doi.org/10.1038/s41598-020-76187-y
Published Online: 2020-11-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tsai, Andrew
Diawara, Oumou
Nahass, Ronald G.
Brunetti, Luigi
Text and Data Mining valid from 2020-11-05
Version of Record valid from 2020-11-05
Article History
Received: 10 July 2020
Accepted: 16 October 2020
First Online: 5 November 2020
Competing interests
: The authors declare no competing interests.